Literature DB >> 27238834

Neurovascular Protective Function of Endothelial Nitric Oxide - Recent Advances.

Zvonimir S Katusic1, Susan A Austin.   

Abstract

In the central nervous system endothelial nitric oxide (NO) is an essential molecule responsible for the preservation of the functional integrity of the neurovascular unit. NO causes vasodilatation and is an important inhibitor of platelet aggregation, smooth muscle cell proliferation, and white blood cell adhesion. In addition, endothelium-derived NO exerts anti-inflammatory and pro-angiogenic effects. More recently, it has been recognized that endothelial NO modulates the expression and processing of amyloid precursor protein in cerebrovascular endothelium and neuronal tissue. Studies in endothelial NO synthase (eNOS) knockout mice indicate that endothelial NO functions as a neurovascular protective molecule during aging. Indeed, genetic inactivation of eNOS exacerbates the detrimental effects of aging on cerebrovascular, microglial, and neuronal functions as well as on cognition. These findings suggest that the preservation of healthy endothelium and normal function of eNOS might be important therapeutic targets. Because the beneficial effects of NO are mostly mediated by the activation of guanylate cyclase/cyclic GMP signaling, inhibitors of phosphodiesterase isoforms, or activation of this signaling with exercise, may offer therapeutic opportunities in the prevention and treatment of aging-induced cognitive decline and Alzheimer's disease. Most recent advances in understanding the molecular mechanisms linking loss of endothelial NO with cognitive decline will be discussed in this review. (Circ J 2016; 80: 1499-1503).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27238834     DOI: 10.1253/circj.CJ-16-0423

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  16 in total

1.  Metabolic syndrome is negatively associated with cognition among endothelial nitric oxide synthase (eNOS)- 786C carriers in schizophrenia-spectrum disorders.

Authors:  A Zarina Kraal; Allison C Moll; Nicole R Arvanitis; Kristen M Ward; Ryan J Dougherty; Tyler B Grove; Kyle J Burghardt; Vicki L Ellingrod
Journal:  J Psychiatr Res       Date:  2019-07-26       Impact factor: 4.791

2.  Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.

Authors:  Jessika Royea; Luqing Zhang; Xin-Kang Tong; Edith Hamel
Journal:  J Neurosci       Date:  2017-05-05       Impact factor: 6.167

Review 3.  Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging.

Authors:  Peter Toth; Stefano Tarantini; Anna Csiszar; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-28       Impact factor: 4.733

4.  Exercise training ameliorates cerebrovascular dysfunction in a murine model of Alzheimer's disease: role of the P2Y2 receptor and endoplasmic reticulum stress.

Authors:  Junyoung Hong; Soon-Gook Hong; Jonghae Lee; Joon-Young Park; Jason L Eriksen; Bridgette V Rooney; Yoonjung Park
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-08       Impact factor: 4.733

5.  Conditioning medicine for ischemic and hemorrhagic stroke.

Authors:  David C Hess; Mohammad Badruzzaman Khan; Pradip Kamat; Kumar Vaibhav; Krishnan M Dhandapani; Babak Baban; Jennifer L Waller; Md Nasrul Hoda; Rolf Ankerlund Blauenfeldt; Grethe Andersen
Journal:  Cond Med       Date:  2021-06

Review 6.  The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches.

Authors:  Han-Yan Zhu; Fen-Fang Hong; Shu-Long Yang
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Mouse models of Alzheimer's disease cause rarefaction of pial collaterals and increased severity of ischemic stroke.

Authors:  Hua Zhang; Bo Jin; James E Faber
Journal:  Angiogenesis       Date:  2018-12-05       Impact factor: 9.596

8.  Combinatorial Treatment Using Umbilical Cord Perivascular Cells and Aβ Clearance Rescues Vascular Function Following Transient Hypertension in a Rat Model of Alzheimer Disease.

Authors:  Paolo Bazzigaluppi; Tina L Beckett; Margaret M Koletar; Mary E Hill; Aaron Lai; Arunachala Trivedi; Lynsie Thomason; Adrienne Dorr; Denis Gallagher; Clifford L Librach; Illsung L Joo; JoAnne McLaurin; Bojana Stefanovic
Journal:  Hypertension       Date:  2019-09-03       Impact factor: 10.190

Review 9.  Cerebrovascular dysfunction with stress and depression.

Authors:  Emily Burrage; Kent L Marshall; Nalini Santanam; Paul D Chantler
Journal:  Brain Circ       Date:  2018-06-29

10.  Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia.

Authors:  Min Zhong; Julan Peng; Lanhua Xiang; Xinhuang Yang; Xianghua Wang; Yanbin Zhu
Journal:  Med Sci Monit       Date:  2020-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.